OUP (Osage University Partners) — Full Portfolio

Beam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases.

BiotechDeep TechMedical DevicesCambridge, US

David R. Liu(Founder and Inventor)J. Keith Joung(Founder and Inventor)Feng Zhang(Founder and Inventor)David R. Liu, Ph.D.(Founder and Inventor)J. Keith Joung, M.D., Ph.D.(Founder and Inventor)Feng Zhang, Ph.D.(Founder and Inventor)

Co-investorsARCH Venture PartnersDreamers VCEight Roads VenturesF-Prime CapitalForesite CapitalGV (Google Ventures)+1 more

Waltham, US

Anil Chitkara(Executive Officer)Michael Ellenbogen(Executive Officer, Director)Kevin O'Brien(Executive Officer)

BoardJoel Cutler(Director)Patrick Ennis(Director)Bilal Zuberi(Director)in

Co-investorsDCVC (Data Collective)Lux Capital

Guardant Health develops blood-based testing (liquid biopsy) for cancer detection and monitoring across all stages of the disease.

BiotechDigital HealthHealthtechMedical DevicesRedwood City, US

AmirAli Talasaz(Executive Officer, Director)inHelmy Eltoukhy(Executive Officer, Director)inMichael Wiley(Executive Officer)

BoardWarren Hogarth(Director)Samir Kaul(Director)in

Co-investors8VCAUTHENTIC VENTURESCota CapitalFelicis VenturesKhosla VenturesLightspeed Venture Partners+6 more

Kura Oncology is a company in the oncology/medtech sector that provides grant support for independent medical education programs designed to enhance healthcare professionals' ability to diagnose and treat patients in Kura Oncology's therapeutic areas of interest.

BiotechDigital HealthMedical DevicesLa Jolla, US

TROY WILSON(Executive Officer, Director)inPINGDA REN(Executive Officer)YI LIU(Executive Officer)Troy Wilson(Founder)inHEIDI HENSON(Executive Officer)ANNETTE NORTH(Executive Officer)

Co-investorsARCH Venture PartnersAvoro Capital AdvisorsEcoR1 CapitalForesite CapitalNextech Invest

Precision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

BiotechDeep TechHealthtechDurham, US

JEFF SMITH(Executive Officer)DEREK JANTZ(Executive Officer, Director)MATTHEW KANE(Executive Officer, Director)Jeff Smith(Co-founder)Derek Jantz(Co-founder)TODD MELBY(Executive Officer)

Co-investorsage1Aliment CapitalBrace PharmaF-Prime CapitalOCV PartnersPontifax AgTech+4 more

Prime Medicine develops one-time genetic therapies using Prime Editing, a gene editing technology developed in David R.

BiotechDeep TechHealthtechMedical Devices

Andrew Anzalone(Co-founder and Head of Platform)David Liu(Co-founder)Allan Reine(Chief Executive Officer)Mohammed Asmal(Chief Medical Officer)Ann Lee(Chief Technical Officer)Svetlana Makhni(Chief Financial Officer)

Co-investorsARCH Venture PartnersGV (Google Ventures)Newpath PartnersF-Prime CapitalSamsara BioCapital

Q32 Bio is a biotechnology company developing therapies for autoimmune and inflammatory diseases, with a scientific focus on the complement system and immune regulation in conditions such as inflammation, autoimmunity and fibrosis.

BiotechHealthtech

Shelia Violette(Founder & Chief Scientific Officer)Michael Holers(Co-founder)Jodie Morrison(Chief Executive Officer)Lee Kalowski(President & Chief Financial Officer)Maria Marzilli(Chief Business Officer)David Appugliese(Senior Vice President, Head of People)

Co-investorsAtlas VentureOrbiMedCU Healthcare Innovation FundSanofi VenturesAgent Capital

Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data.

BiotechDigital HealthFemTechHealthtechSalt Lake City, US

Douglas Fisher(Executive Officer)Jay Moyes(Executive Officer)Gregory C. Critchfield(Executive Officer, Director)Andrew A. Sauter(Executive Officer)

BoardMansoor Mirza(Director)Ryan M. Trimble(Director)

Co-investorsaMoonExcelestar VenturesUpStart VenturesVivo CapitalCatalyst Health VenturesDomain Associates

Spero Therapeutics is a clinical-stage biopharmaceutical company developing medicines for immune-mediated diseases, led by SP001, a third-generation anti-CD40L antibody targeting IgG4-related disease.

BiotechCambridge, US

Ankit Mahadevia(Executive Officer, Director)Stephen Garbacz(Executive Officer)

BoardJean-Francois Formela(Director)inReza Halse(Director)Casper Breum(Director)Vikas Goyal(Director)

Co-investorsHEALTHCARE ROYALTY PARTNERSMRL Ventures FundRA CapitalAlphabetAtlas Venture

Veradermics is developing VDPHL01, an extended-release oral minoxidil tablet intended as a non-hormonal prescription treatment for pattern hair loss in women and men.

BiotechHealthtechWest Hartford, US

Reid Waldman(Chief Executive Officer and Board Member)inTim Durso(Chief Technical Officer)Dominic Carrano(Chief Financial Officer and Treasurer)Mark Neumann(Chief Commercial and Strategy Officer)John W. Childs(Director)Jane Grant-Kels(Director)

Co-investorsLongitude CapitalConnecticut InnovationsSR One Capital Management

Co-investors5AM VenturesRA Capital

Eridu develops networking infrastructure optimized for artificial intelligence workloads.

AI & Machine LearningCloud ComputingDeep TechHardwareSaratoga, US

Drew Perkins(CEO and founder)inChristian Gallagher(Director)Jagdeep Singh(Director)Omar Hassen(Director)Dipender Saluja(Director)Brian Kinard(Executive Officer)

Co-investorsBosch VenturesCatapult VenturesMatter Venture PartnersSocratic PartnersZelda VenturesBlack Opal Ventures+12 more

Aerie Pharmaceuticals develops ophthalmic pharmaceutical products including Rocklatan and Rhopressa for glaucoma and ocular hypertension, and AR-15512 for dry eye disease.

BiotechHealthtechMedical DevicesBedminster, US

DAVID GRYSKA(Director)VICENTE ANIDO(Executive Officer, Director)MURRAY GOLDBERG(Director)ANAND MEHRA(Director)BRIAN LEVY(Executive Officer)GERALD CAGLE(Director)

Co-investorsAlta PartnersAvoro Capital AdvisorsForesite CapitalSofinnova Ventures

Boston, US

Co-investorsRA Capital

Agita Labs develops hardware security and computer architecture technology focused on secure computation and side-channel resistance techniques.

CybersecurityDeep TechHardwareAnn Arbor, US

Valeria Bertacco(Co-founder)Todd Austin(Co-founder)Amy Wirth(Chief Financial Officer)Lip-Bu Tan(Director)

Algorithmia offers an enterprise AI platform for developing, deploying, and governing machine learning models and AI applications, with tooling tailored to roles across data science, engineering, DevOps, and IT teams.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSeattle, US

Kenneth F. Daniel(Executive Officer, Director)Diego M. Oppenheimer(Executive Officer, Director)in

BoardTimothy Porter(Director)inAnna Patterson(Director)in

Co-investorsGradient VenturesMadrona Venture GroupNorwest Venture PartnersWork-Bench

Develops therapeutics targeting altered NAD metabolism in cancer, using IP licensed from Yale University.

BiotechNew Haven, US

Barbara Fox(Executive Officer, Director)Nicholas J Galli(Executive Officer, Director)Kevin L. Rakin(Executive Officer, Director)Stanley Choy(Executive Officer)Ranjit Bindra(Director)

BoardColleen Cuffaro(Director)in

Co-investorsCanaan PartnersConnecticut InnovationsHighCape Capital

Antiva Biosciences develops a topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions, utilizing antiviral prodrug chemistry.

BiotechFemTechHealthtechMedical DevicesRedwood City, US

Karl Y. Hostetler(Executive Officer, Director)Gail Maderis(Director)Kristine Ball(Executive Officer, Director)Elaine Chien(Executive Officer)Sarah Walter(Executive Officer)Raju Gadiraju(Executive Officer)

Co-investorsAdjuvant CapitalBrace PharmaCanaan PartnersLumira VenturesMPM BioImpactSofinnova Ventures+3 more

BiotechEvanston, US

Joseph R. Moskal(Chief Scientific Officer)Torsten M. Madsen(Chief Marketing Officer)Ashish Khanna(Secretary & Chief Business Officer)Norbert G. Riedel(Chief Executive Officer)

BoardLiam Ratcliffe(Director)Terry P. Gould(Director)

Co-investorsBain Capital Life SciencesFrazier Life SciencesLatterell Venture PartnersLongitude Capital

Arrakis Therapeutics develops RNA-targeted small-molecule (rSM) medicines, working independently and with partners to create drug candidates aimed at the root causes of disease.

AI & Machine LearningBiotechDeep TechHealthtechCambridge, US

Michael Gilman(Executive Officer, Director)Mark DeLong(CEO)David Neafus(Executive Officer)Russell C. Petter(Executive Officer)

BoardColleen Cuffaro(Director)inAlan E. Walts(Director)in

Co-investorsCanaan PartnersPfizer VenturesAdvent Life SciencesNextech InvestPfizer Venture InvestmentsvenBio Partners+1 more

Arsenal Biosciences is a clinical-stage company developing programmable cell therapies to treat solid tumors.

BiotechHealthtechMedical DevicesSouth San Francisco, US

Ken Drazan(Founder)James Ahlers(Executive Officer)Kenneth Drazan(Executive Officer, Director)Irene Pleasure(Executive Officer)Margaret Nibbi(Executive Officer)

BoardValentin Barsan(Director)

Co-investorsARCH Venture PartnersHitachi VenturesKleiner PerkinsSoftBank Vision FundWestlake Village BioPartners

AssetWatch provides cloud-based asset monitoring software and sensor technology to help manufacturing and industrial facilities prevent unplanned equipment downtime.

Advanced ManufacturingEnterprise SoftwareIoTSaaSWesterville, US

William Zell(Executive Officer, Director)William Ruff(Executive Officer)Robert Lee(Director)Tad Dritz(VP of Development)Jeff Haskett(COO)Brian Graham(Executive Officer, Director)in

Co-investorsCerity Partners VenturesG2 Venture PartnersHarmonic Growth PartnersJobsOhio VenturesMonte Carlo CapitalTriangle Peak Partners+4 more

Co-investorsHatteras Venture PartnersLightstone Ventures

Co-investorsBioAdvancePfizer Venture Investments

Biotechnology company developing drugs to treat aging and associated diseases

Co-investorsFelicis VenturesSV Health Investors

Biohaven is a biopharmaceutical company that discovers, develops, and commercializes treatments across immunology, obesity, neuroscience, and oncology, targeting rare and common diseases with limited treatment options.

BiotechHealthtech

Vlad Coric(Chairman & Chief Executive Officer)

Co-investorsAisling CapitalAPERTURE Venture PartnersConnecticut Innovations

BiotechSouth San Francisco, US

Wendye Robbins(Executive Officer, Director)

BoardLuke Evnin(Director)inCameron Wheeler(Director)Peter van Vlasselaer(Director)Elaine Jones(Director)William Slattery(Director)

Co-investorsBay City CapitalPfizer Venture Investments+ND CapitalMPM BioImpact

New York, US

William J. O'Farrell(Executive Officer, Director)Michael Black(Director)

BoardJoseph Ferrara(Director)Lawrence Lenihan(Director)

Brimstone develops co-production processes to manufacture cement, steel, aluminum, and other critical minerals from a single feedstock in an integrated facility.

Advanced ManufacturingCircular EconomyCleantechConstruction TechNew MaterialsOakland, US

Cody Finke(CEO)Hugo LeandriCody Finke, Ph.D.(Founder)in

Co-investorsAccelr8Collaborative FundCreative Destruction Lab (CDL)DCVC (Data Collective)Fifth WallGVP Climate+4 more

BiotechLafayette, US

Peter Emtage(Executive Officer)Greg Giotta(Executive Officer)Brian Atwood(Executive Officer, Director, Promoter)

BoardFred Cohen(Executive Officer, Director, Promoter)Brook Byers(Director)inArie Belldegrun(Director)

Co-investorsKleiner PerkinsMission Bay Capital

Clarifai developed AI inference technology and compute orchestration software for running and optimizing machine learning models at scale.

AI & Machine LearningCloud ComputingData & InfrastructureNew York, US

Matthew Zeiler(Executive Officer, Director)in

BoardAlbert Wenger(Director)in

Co-investorsBright Pixel CapitalCorazon CapitalGV (Google Ventures)Lux CapitalMenlo VenturesNew Enterprise Associates (NEA)+11 more

Caidya is a contract research organization (CRO) that provides scientific, medical, and operational support for clinical development and cross-border clinical trials.

BiotechDigital HealthHealthtechMorrisville, US

Mark Ubert(Executive Officer)Jesse Watson(Director)Brian Carney(Director)Jeff L. Williams(Executive Officer, Director)Melissa Daniels(Director)Christopher K. Porter(Executive Officer)

Co-investorsCreathor VenturesHatteras Venture Partners

Corelight provides network detection and response (NDR) software that uses agentic triage to automatically consolidate security alerts into entity-centric cases with evidence-backed investigation summaries.

AI & Machine LearningCybersecurityEnterprise Software

Seth Hall(Founder)in

Co-investorsAccelCisco InvestmentsDelta-v CapitalEnergy Impact PartnersFlucas VenturesH.I.G. Capital+3 more

Cyteir is a clinical-stage oncology company developing CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters.

BiotechHealthtechCambridge, US

Kevin Mills(Executive Officer, Director)Ronald Goldstein(Executive Officer)Donald Corcoran(Executive Officer, Director)Markus Renschler(Director)

BoardTimothy Romberger(Director)Barry Mills(Director)

Co-investorsDroia VenturesLightstone Ventures

DELFI Diagnostics develops FirstLook Lung, a blood-based laboratory test for lung cancer screening that identifies genome-wide alterations in individuals eligible for screening.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBaltimore, US

Victor Velculescu(Executive Officer, Director, Promoter)inPeter Bach(Executive Officer)Jennifer Buechel(Executive Officer)Douglas Schenkel(Executive Officer)Nicholas Dracopoli(Executive Officer)

BoardRishi Gupta(Director)in

Co-investorsAV8 VenturesForesite CapitalIllumina VenturesMenlo VenturesOpen Field CapitalOrbiMed+3 more

Clinical-stage biopharmaceutical company combining innovative chemistry with validated biology to make medicines more accessible for chronic autoimmune and inflammatory diseases.

Co-investorsSamsara BioCapital

Dracen Pharmaceuticals is a private drug developer working at the intersection of cancer metabolism and immuno-oncology, developing glutamine antagonists that inhibit tumor glutamine metabolism and remodel the tumor microenvironment.

BiotechHealthtechBaltimore, US

Robert Wild(Co-founder & Chief Scientific Officer)Thomas M. Estok(Chief Executive Officer, President and Treasurer)Drew Pardoll, M.D., Ph.D.(Director)

BoardJonathan Leff(Director)Robert Jackson(Director)

Co-investorsBiotech Investments S.R.ODeerfield Management Company

BiotechSouth San Francisco, US

Julie Anne Smith(Executive Officer, Director)R. Sanders Williams(Director)Perry Karsen(Director)Judith Li(Director)Markus Goebel(Director)Peter Moldt(Director)

eFFECTOR Therapeutics was a clinical-stage biopharmaceutical company.

BiotechSolana Beach, US

Stephen F. Worland, Ph.D.(Executive Officer, Director)Alana McNulty(Executive Officer)

BoardSimeon George(Director)Jonathan Root(Director)inKen Haas(Director)Laurence Lasky(Director)

Co-investorsAstellas Venture Management LLCMission Bay CapitalMission BiocapitalPfizer Venture InvestmentsUS Venture PartnersSofinnova Ventures

Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.

BiotechBrookline, US

Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)

BoardGeorge M. Church(Director)

Co-investorsAlta PartnersARCH Venture PartnersCatalio Capital Management, LPKhosla Venturesb2ventureKendall Capital Partners

Elementary builds data observability tools that monitor data quality and reliability for modern data teams.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareTel Aviv-Yafo, IL

Maayan Salom(Founder)inOr Avidov(Founder)in

Co-investorsModern TechnicalY Combinator

Elementary Robotics builds a factory AI stack for automated visual quality inspection, combining machine vision hardware (cameras, lighting, edge controllers), self-training defect-detection AI (VisionStream), and a cloud platform (QualityOS) for traceability and analytics.

Advanced ManufacturingAI & Machine LearningRobotics

Co-investorsRiot VenturesThundermark CapitalUbiquity Ventures

Everactive develops ultra-low power, self-powered systems-on-chip (SoCs) for Ambient IoT devices that sense, process, and wirelessly transmit data using harvested environmental energy instead of batteries.

HardwareIoTSemiconductorsSan Jose, US

Benton Calhoun(Executive Officer, Director)inDavid Wentzloff(Executive Officer, Director)Brendan R Richardson(Executive Officer, Director)

BoardGeorge Kastendike(Director)Greg Papadopoulos(Director)Jack Busch(Director)

Co-investorsBlue Bear Capital PartnersNew Enterprise Associates (NEA)ABB Technology VenturesOsage University Partners

Co-investorsCambium CapitalCandou VenturesCelesta CapitalCelesta CapitalEastlink Capital PartnersLaunch NY+2 more

Seattle biotech that developed FDY-5301 for cardiac and skeletal muscle injury; ceased operations in February 2026.

BiotechSeattle, US

Mark Roth(Executive Officer, Director, Promoter)Brian Blackman(Executive Officer)Simon Tulloch(Executive Officer)Stephen Hill(Executive Officer, Director)

BoardPaulina Hill(Director)Steven Gillis(Executive Officer, Director, Promoter)in

Co-investorsARCH Venture PartnersPolaris Partners

Fortis Therapeutics develops precision cancer therapies that target CD46 proteins on tumor cells while sparing healthy tissue.

BiotechHealthtech

Co-investorsAvalon BioVenturesVivo CapitalLilly Asia VenturesOsage University Partners

Hack The Box provides hands-on training and simulation platforms for cybersecurity blue teams, including labs, courses, and incident response exercises designed to develop skills in SOC operations, digital forensics, and threat hunting.

CybersecurityDeveloper ToolsEdTechEnterprise Software

Co-investorsBrighteye VenturesMarathon Venture CapitalPaladin Capital Group

Clinical-stage genetic medicines company using human-derived AAV vectors and nuclease-free gene editing for rare diseases.

BiotechBedford, US

Siyamak Rasty(Executive Officer)Albert Seymour(Executive Officer)

BoardSteven Gillis(Director)Arthur Tzianabos(Executive Officer, Director)Kush Parmar(Director)inRichard Gregory(Director)

Co-investors5AM VenturesARCH Venture PartnersAlexandriaDeerfield Management CompanyHBM Healthcare InvestmentsMaverick Ventures+4 more

HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery.

HealthtechMedical DevicesLexington, US

Carl Vause(Executive Officer, Director)Mira Sahney(Executive Officer, Director)David Myung(Director)

BoardMichael Hawkins(Director)Wende Hutton(Director)inWilliam Harrington(Director)in

Co-investorsCanaan PartnersTreo Ventures, Llc

BiotechSouth San Francisco, US

Kirk Dornbush(Executive Officer, Director)William Greene(Executive Officer, Director)

BoardJohan Kordel(Director)Bruce Robertson(Director)Todd Foley(Director)Peter Hirth(Director)

BiotechSeattle, US

Carlos V. Paya(Executive Officer, Director)Ed Penhoet(Director)Stephen R. Brady(Executive Officer)Jan Henrik ter Meulen(Executive Officer)David Baltimore(Director)William Ringo(Director)

Co-investorsSanofi Ventures

Infinite Uptime builds PlantOS, a prescriptive AI platform for heavy manufacturing that reads mechanical and process-induced fault signatures to tell plant operators which equipment fault to fix, why, and by when.

Advanced ManufacturingAI & Machine LearningIoTMenlo Park, US

Raunak Bhinge(Executive Officer, Director)Jean-David Margulici(Executive Officer, Director)

Co-investorsDorm RoomGiTV, Inc.TDK VenturesTrifecta Capital AdvisorsVenturEastAvataar Venture Partners+1 more

BiotechPhiladelphia, US

Philip R. Johnson, M.D.(Executive Officer, Director)Dora Mitchell(Executive Officer)Lori Forrest(Executive Officer)Leon Moulder, Jr.(Director)Benjamin Lund(Director)

BoardTomas Kiselak(Director)

Co-investorsPfizer Venture Investments

Vertically-integrated machine learning platform for healthcare powering transition to value-based care with predictive analytics.

Co-investorsMindset VentureOsage University Partners

BiotechNew Haven, US

Joseph Schlessinger(Director)Michael Schmertzler(Executive Officer, Director)Stanley Choy(Executive Officer)Yaron Hadari(Executive Officer)W. Bradford Middlekauff(Executive Officer)

BoardAxel Bolte(Director)

Kymeta develops flat-panel satellite antennas and connectivity terminals, including its u5 and u8 product lines, that switch between LEO and GEO networks for mobile land and maritime use.

Defense TechHardwareSpace TechRedmond, US

Marc Stolzman(Executive Officer)Bill Marks(Executive Officer)Keith Cochran(Executive Officer)Manny Mora(President and CEO)inAnne(Chief Financial Officer)inRyan(Chief Scientist)in

Co-investorsLux CapitalManta Ray VenturesTectonic VenturesOsage University Partners

BiotechBlacksburg, US

Josep Bassaganya-Riera(Executive Officer, Director)Christopher Garabedian(Director)

Global leader in silicon photonics, first to achieve direct 'fiber to the chip' integration on CMOS.

Carlsbad, US

Eli Yablonovitch(Director)Greg Young(Executive Officer, Director)Tom Foody(Executive Officer)

BoardAndy Rappaport(Director)Rohini Chakravarthy(Director)Forest Baskett(Director)

Co-investorsAugust CapitalCisco InvestmentsTEL Venture Capital, Inc.

MC10 developed conformal BioStamp wearable sensors and clinical analytics for physiological data capture in clinical research.

BiotechDigital HealthHealthtechMedical DevicesLexington, US

John Rogers(Director)David Icke(Executive Officer, Director)Alice Sansone(Executive Officer)Steven N. Tannenbaum(Executive Officer)Scott D. Pomerantz(Executive Officer, Director)

BoardMarc Singer(Director)in

Co-investorsBraemar Energy VenturesMitsui Global InvestmentWindham Capital PartnersNorth Bridge Venture Partners

Singapore-based immune engineering company developing novel cellular therapies for T-cell malignancies and autoimmune diseases.

Singapore

Co-investorsClavystBioLightstone Ventures

Menlo Security provides a browser security platform that protects both human users and AI agents through a hybrid architecture combining local security controls with cloud-based threat protection.

AI & Machine LearningCybersecurityEnterprise SoftwareMountain View, US

Amir Ben-Efraim(Founder)Poornima DeBolle(Founder)

Co-investorsBaruch Future VenturesEngineering CapitalJunipero

Metalenz develops metasurface optics technology for optical sensing in consumer and industrial devices.

Deep TechHardwareSemiconductorsStoneham, US

Robert Charles Devlin(Executive Officer, Director)Federico Capasso(Director)Rob Devlin(Founder)in

BoardXuhui Shao(Director)in

Co-investorsBantam GroupBraemar Energy VenturesFoothill VenturesGlobal BrainIntel CapitalM Ventures+6 more

Co-investorsLongwood Fund

Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment.

HealthtechMedical Devices

Co-investorsGreen Park & Golf VenturesUS Venture Partners

Co-investorsF-Prime Capital

Nocion Therapeutics develops small molecule charged sodium channel blockers (nocions) designed to silence overactive sensory nerves.

BiotechHealthtechMedical DevicesWatertown, US

MATTHEW FRANKEL(Executive Officer)PETER COUROSSI(Executive Officer)RICHARD BATYCKY(Executive Officer, Director)JAMES ELLIS(Executive Officer)MICHAEL LIPP(Executive Officer)CHRISTOPHER SILBER(Executive Officer)

Co-investorsCanaan PartnersF-Prime CapitalMission BiocapitalMonograph Capital PartnersOsage University Partners

Opsys develops solid-state scanning LiDAR sensors with no moving parts, using VCSEL and SPAD chip technology for autonomous driving and industrial applications.

AI & Machine LearningDeep TechHardwareRoboticsIsrael, IL

Co-investors83NorthSaban VenturesTransLink Capital

Overland AI develops ground autonomy solutions for military vehicles and land operations, enabling autonomous mobility without human operators.

AI & Machine LearningDefense TechRoboticsSeattle, US

Byron Boots(Co-Founder & CEO)inStephanie Bonk(Co-Founder & President)inGreg Okopal(Co-Founder & COO)inJonathan Fink(Executive Officer)

BoardChristopher Morales(Director)

Co-investors8VCAscend Venture CapitalPoint72 VenturesVoyager CapitalCubit CapitalShasta Ventures+3 more

BiotechHorsham, US

Lorenzo Pellegrini(Executive Officer, Director)Marella Thorell(Executive Officer)John Alexander Martin(Executive Officer, Director)Sanford Zweifach(Director)Frank Condella(Director)

BoardFrancesco DeRubertis(Director)

Somerville, US

Samuel Anthony(Executive Officer, Director)Kshitij Misra(Executive Officer, Director)John Harris(Director)

Picwell operates ALEX, a benefits decision-support platform that combines plan recommendations, enrollment, benefits administration, and year-round guidance for employees.

HR TechInsurTechSaaSPhiladelphia, US

Thomas Baker(Executive Officer, Director)Jonathan Thompson Kolstad(Executive Officer, Director)Robert James Town(Executive Officer, Director)Jay Silverstein(Executive Officer, Director)Anirudh Vemprala(Executive Officer, Director)

BoardKevin Hill(Director)

Co-investorsBlue Venture FundsMassMutual VenturesOsage University Partners

HealthtechSan Francisco, US

Matthew F. Krummel, Ph.D.(Director)Steven P. James(Executive Officer, Director, Promoter)Leon Chen, Ph.D.(Director)Carol Gallagher(Director)Joshua Resnick, M.D.(Director)

BoardMichael Powell(Director)

Co-investorsMission Bay CapitalMission BiocapitalNew Enterprise Associates (NEA)Sofinnova VenturesSofinnova Venture Partners

PMV Pharma develops precision oncology therapies that target and structurally correct mutated p53 proteins to restore their tumor-suppressing function.

BiotechHealthtechCranbury, US

David H. Mack, Ph.D.(Founder)inDavid Mack(Executive Officer, Director)Arnold Levine(Director)

BoardPeter Thompson(Director)Steve Winick(Director)Arnold Oronsky(Director)

Co-investorsAvoro Capital AdvisorsNextech InvestRA CapitalOrbiMedOsage University Partners

Precede Biosciences develops a blood-based diagnostic platform that profiles gene expression from cell-free DNA to reveal disease biology at the transcriptional level for drug developers and clinical trials.

AI & Machine LearningBiotechDigital HealthBoston, US

Rehan Verjee(Co-Founder, Chief Executive Officer, Board Director)Sylvan Baca(Co-Founder; Assistant Professor of Medicine, Dana-Farber Cancer Institute)Toni Choueiri(Co-Founder; Director, Lank Center for GU Oncology, Dana-Farber Cancer Institute)Matthew Freedman(Co-Founder; Professor of Medicine, Dana-Farber Cancer Institute)

Co-investorsIllumina Ventures5AM VenturesLilly Asia VenturesOsage University Partners

Quantum Circuits develops superconducting quantum computers using dual-rail qubits with built-in error detection, designed to accelerate the path to fault-tolerant quantum computing.

Advanced ManufacturingDeep TechHardwareQuantum ComputingMadison, US

Rob Schoelkopf(Sterling Professor, Founder)Luigi FrunzioRay Smets

Co-investorsARCH Venture PartnersCanaan PartnersConnecticut InnovationsF-Prime CapitalFitz Gate VenturesTribeca Venture Partners

Quintessent develops optical connectivity solutions to address chip-to-chip communication bottlenecks in large-scale computing and AI systems.

AI & Machine LearningCloud ComputingDeep TechHardwareSemiconductorsSanta Barbara, US

Alan Liu(CEO, Co-Founder & Board Member)inBrian Koch(VP of Engineering & Co-Founder)inJohn Bowers(Chairman of the Board & Co-Founder)

Co-investorsEntrada VenturesFoothill VenturesM VenturesSierra Ventures

San Diego biopharmaceutical company developing GPCR-targeted immune-inflammatory drugs; acquired by Celgene for ~$7.2B in 2015.

BiotechSan Diego, US

Marcus Boehm(Executive Officer)Robert Peach(Executive Officer)Raymond Stevens(Director)Faheem Hasnain(Executive Officer, Director)James Schmidt(Executive Officer)Chrysa Mineo(Executive Officer)

Co-investorsARCH Venture PartnersVenrock

ReCode develops mRNA and gene correction therapeutics for genetic diseases, using proprietary lipid nanoparticle technology to deliver treatments to specific organs.

AI & Machine LearningBiotechHealthtechMedical DevicesMenlo Park, US

Dr. Daniel J. SiegwartArthur E Johnson(Executive Officer, Director)

Co-investorsAju IB Invesment CorporationEcoR1 CapitalEvolution VC PartnersMPM BioImpactOrbiMedPfizer Venture Investments+6 more

Redona Therapeutics develops novel therapeutics targeting enzymes involved in the dysregulation of RNA and DNA processing and signaling, which contribute to serious diseases such as cancer and autoimmune conditions.

Biotech

Co-investorsAstellas Venture Management LLCSofinnova Partners

BiotechLexington, US

Victoria M. Richon(Executive Officer, Director)

BoardCameron Wheeler(Director)Jonathan Root(Director)Laurence Lasky(Director)

Co-investorsAvego BioScience CapitalPeregrine VenturesAbbVieNovartis Venture FundThe Column Group

Sana is a biotech company developing engineered cell medicines, including gene therapies for gene modification and delivery, cell replacement therapies using stem cell biology, and manufacturing solutions to improve patient access to these treatments.

BiotechHealthtechMedical DevicesSeattle, US

Steve Harr(President and Chief Executive Officer)

Co-investorsAmerican Family VenturesARCH Venture PartnersF-Prime CapitalFlagship PioneeringInnovating CapitalJDRF T1D Fund+1 more

Satsuma Pharmaceuticals develops therapeutics for the acute treatment of migraine, including an approved dihydroergotamine nasal powder product (Atzumi/STS101).

BiotechHealthtechMedical DevicesSouth San Francisco, US

John Kollins(Executive Officer, Director)Tadayoshi Iwashima(Executive Officer)Thomas B. King(President and Board Director)Rob Janosky(Chief Commercial Officer)Tom O'Neil(Chief Financial Officer)David Prichard(Chief Operating Officer)

Co-investorsVivo CapitalRed Tree Venture

Co-investorsBoutique Venture PartnersvenBio Partners

SiFive develops processor IP based on the open-standard RISC-V instruction set architecture, offering customizable and scalable chip designs.

Deep TechHardwareSemiconductorsSan Francisco, US

Yunsup Lee(Executive Officer, Director)Krste Asanovic(Director)Andrew WatermaninStefan A Dyckerhoff(Executive Officer, Director)Naveed Sherwani(Executive Officer)Patrick Little(CEO)

Co-investorsBerkeley SkyDeck FundCoatue ManagementIntel CapitalProsperity7 VenturesQualcomm VenturesAtreides Management+6 more

Snowcap Compute develops superconducting computing platforms using Josephson Junctions to replace semiconductor transistors, delivering orders-of-magnitude greater energy efficiency for AI and high-performance computing workloads.

AI & Machine LearningDeep TechSemiconductorsSan Francisco, US

Anna Herr(Executive Officer)Quentin Herr(Executive Officer)Michael Shamus Lafferty(Executive Officer, Director)

BoardPat Gelsinger(Director)inRichard Hyman(Director)

Co-investorsPlayground GlobalCambium CapitalPage One Ventures

Sonoma Biotherapeutics develops engineered regulatory T cell therapies to treat autoimmune and inflammatory diseases.

BiotechHealthtechMedical DevicesSouth San Francisco, US

Jeffrey Bluestone(Executive Officer, Director, Promoter)

BoardFan Yu(Director)Maggie Wilderotter(Director)Toni Hoover(Director)Terry Rosen(Director)Richard Klausner(Director)

Co-investors8VCARCH Venture PartnersFrazier Life SciencesJDRF T1D FundLAVLifeforce Capital+1 more

StreetLight provides big data analytics for transportation planning and infrastructure investment decisions.

Climate TechData & InfrastructureGovTechLogistics & Supply ChainMobility & TransportationSan Francisco, US

Paul Friedman(Founder, Chief Technology Officer)Laura Schewel(Executive Officer, Director, Promoter)Clay Collier(Director)

BoardBill Perry(Director)Scott Pinizzotto(Director)Marc Singer(Director)in

Co-investorsACTIVATE CAPITAL PARTNERS

Clinical-stage biotech expanding the genetic alphabet with synthetic nucleotides; acquired by Sanofi for $2.5B in 2020.

BiotechLa Jolla, US

Jay Lichter(Director)Douglas Downs(Executive Officer)Floyd Romesberg(Director)Court Turner(Executive Officer, Director)

Co-investorsAvalon BioVenturesBoutique Venture PartnersCorrelation VenturesRA CapitalvenBio Partners

Tessera provides a multi-agent AI platform for enterprise system modernization, automating processes across ERP, CRM, HCM, and finance systems with governed execution.

AI & Machine LearningEnterprise SoftwareSaaS

Kabir Nagrecha(Chief Executive Officer)inMing Chang(Chief Operating Officer)inAnirudh Sriram(Chief Technology Officer)inPrakash Gupta(Chief Revenue Officer)in

Co-investorsAndreessen HorowitzFoundation CapitalMyriad Venture PartnersOsage University Partners

BiotechSan Diego, US

Alain Baron(Executive Officer, Director)JeenJoo Kang(Director)Robert Tjian(Director)Marcus Boehm(Executive Officer)

BoardAndrew Schwab(Director)in

Co-investors5AM VenturesAvego BioScience CapitalNew Enterprise Associates (NEA)Sanofi VenturesThe Column GroupAbingworth+3 more

Somerville, US

Russ Wilcox(Executive Officer, Director)

BoardCraig Shapiro(Director)

Co-investorsWorkshop Venture Partners

Arcadia (urjanet.com) offers a platform that unifies utility bill and interval data, tariff and energy rate calculations, and solar and storage analysis into energy data and analytics.

CleantechClimate TechData & InfrastructureEnergyAtlanta, US

SANJOY MALIK(Executive Officer, Director)

BoardPETER KIGHT(Director)STEVE FREDRICK(Director)inSIG MOSLEY(Director)DAVID RATCLIFFE(Director)

Co-investorsCorrelation VenturesGrotech VenturesOak HC/FT

Develops electroswing adsorption technology for scalable and cost-effective carbon capture and removal

Co-investorsAzolla VenturesLOWERCARBONLowercarbon Capital

Verve Motion develops the SafeLift exosuit, a wearable device designed to reduce workplace injuries and increase productivity for physically demanding jobs.

Future of WorkHardwareLogistics & Supply ChainRobotics

Ignacio Galiana(Founder)in

Co-investorsConstruct CapitalCybernetix VenturesFounder CollectivePillar VCSafar Partners

Virtue AI offers an enterprise AI security platform that applies real-time guardrails, red-teaming, and compliance controls to AI models and agentic systems.

AI & Machine LearningCybersecurityEnterprise SoftwareSan Francisco, US

Sanmi Koyejo(Founder)

Co-investorsWalden Catalyst

Fort Lee, US

Alexander Gaeta(Executive Officer, Director)Vivek Raghunathan(Executive Officer, Director)inYoshitomo Okawachi(Executive Officer)Alexander Kash(Executive Officer, Director)

BoardJames Scapa(Director)

Co-investorsCisco InvestmentsFathomFathom FundIAG Capital PartnersLifeX VenturesNVIDIA